Synthetic Biology

Researchers Engineer Stable FGF1 to Boost Healing and Metabolism
Biotech & Bioprocessing Researchers Engineer Stable FGF1 to Boost Healing and Metabolism

A single targeted mutation known as R126E has proven capable of enhancing the potency of growth-promoting proteins while making them more resistant to chemical degradation. This finding comes at a time when regenerative medicine is seeking more durable solutions for patients with impaired healing

CRISPRLungo Enhances Precision in Long-Read DNA Editing Analysis
Research & Development CRISPRLungo Enhances Precision in Long-Read DNA Editing Analysis

CRISPRLungo focuses on classifying the complete diversity of editing outcomes instead of reducing results to a single percentage of efficiency. As gene-editing technology transitions from a research laboratory curiosity to a cornerstone of clinical medicine and industrial agriculture, the demand

Can AI Bridge the Industrial Biomanufacturing Gap?
Biotech & Bioprocessing Can AI Bridge the Industrial Biomanufacturing Gap?

The maturation of artificial intelligence in the life sciences is now being judged by its ability to facilitate commercial execution rather than just generating digital designs. The recent acquisition of the American biotechnology firm Genomatica by Copenhagen-based Again signals a tectonic shift

Can Genetic Switches Enable Large-Scale Bone Repair?
Biotech & Bioprocessing Can Genetic Switches Enable Large-Scale Bone Repair?

Identifying CD31 protein expression in engineered tissue constructs serves as a vital indicator that a functional internal blood vessel network has begun to take shape. For patients grappling with catastrophic bone injuries or the aftermath of tumor removals, the quest for a permanent solution

Data Standards Bring Engineering Rigor to Biology
Tech & Innovation Data Standards Bring Engineering Rigor to Biology

Automated robotic systems at facilities like the Living Measurement Systems Foundry are now essential for removing human error and generating the high-fidelity data needed for scientific discovery. Professor Chris Myers, a prominent researcher from the University of Colorado Boulder, has

How Will the Again-Geno Deal Revolutionize Biomanufacturing?
Management & Regulatory How Will the Again-Geno Deal Revolutionize Biomanufacturing?

The industrial landscape is currently undergoing a seismic shift as the acquisition of Genomatica by the Danish innovator Again creates a formidable powerhouse capable of redefining the boundaries of sustainable chemical production. This merger represents more than just a corporate expansion; it is

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later